Indeed, pharmacological blockade of TRPV1 has recently emerged as potential novel therapeutic possibility in managing AD [293], and according to certain in vitro and animal data, TRPV3 antagonists also seem to be promising anti-AD candidate drugs [119,121,244]. The gene discussed is TRPV1; the disease is Alzheimer disease.